Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Beneficial Ownership Report · SCHEDULE 13G/A

Freenome, Inc.

FRNMNASDAQEQUITYCurrent

Beneficial Ownership Report

Filed Nov 16, 2026Accepted Nov 16, 2026, 9:54 PM ESTFiling CIK 2017526Accession 0001104659-26-128738
Share

Structured filing — SCHEDULE 13G/A

primary_doc.xml

Open full document ↗

Amendment · This filing reports the amendment as submitted.

Subject company

Company
Freenome, Inc.
Company CIK
0002017526
Street
Genesis Marina, 3300 Marina Blvd
City
Brisbane
State / country code
CA
Postal code
94005

Statement details

Amendment number
3
Security class
Common Stock, par value $0.0001 per share
Event date
09/30/2026
Rule designation
Rule 13d-1(b)

Reporting person 1

Name
ADAR1 Capital Management, LLC
Citizenship / organization
TX
Reporting person type
IA · OO
Group designation
b
Aggregate amount owned
1,645,800.00
Percent of class
1.5
Sole voting power
0.00
Shared voting power
1,645,800.00
Sole dispositive power
0.00
Shared dispositive power
1,645,800.00
Aggregate excludes certain shares
N
Comments
Includes (i) 1,403,069 shares of common stock, par value $0.0001 per share ("Common Stock"), held by ADAR1 Partners, LP, (ii) 222,361 shares of Common Stock held by Spearhead Insurance Solutions IDF, LLC and (iii) 20,370 shares of Common Stock held by other separately managed accounts as of September 30, 2026. As the investment manager of ADAR1 Partners, LP, as the sub-advisor of Spearhead Insurance Solutions IDF, LLC and as the manager of the separately managed accounts referenced above, ADAR1 Capital Management, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP, Spearhead Insurance Solutions IDF, LLC and the separately managed accounts. Based on 110,870,300 shares of Common Stock of Freenome, Inc. (the "Issuer") outstanding as of September 30, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026, filed with the Securities and Exchange Commission on November 12, 2026.

Reporting person 2

Name
ADAR1 Capital Management GP, LLC
Citizenship / organization
TX
Reporting person type
OO
Group designation
b
Aggregate amount owned
1,403,069.00
Percent of class
1.3
Sole voting power
0.00
Shared voting power
1,403,069.00
Sole dispositive power
0.00
Shared dispositive power
1,403,069.00
Aggregate excludes certain shares
N
Comments
Includes 1,403,069 shares of common stock, par value $0.0001 per share ("Common Stock") directly held by ADAR1 Partners, LP as of September 30, 2026. As the general partner of ADAR1 Partners, LP, ADAR1 Capital Management GP, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP. Based on 110,870,300 shares of Common Stock of Freenome, Inc. (the "Issuer") outstanding as of September 30, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026, filed with the Securities and Exchange Commission on November 12, 2026.

Reporting person 3

Name
Daniel Schneeberger
Citizenship / organization
V8
Reporting person type
HC · IN
Group designation
b
Aggregate amount owned
1,645,800.00
Percent of class
1.5
Sole voting power
0.00
Shared voting power
1,645,800.00
Sole dispositive power
0.00
Shared dispositive power
1,645,800.00
Aggregate excludes certain shares
N
Comments
Includes (i) 1,403,069 shares of common stock, par value $0.0001 per share ("Common Stock"), held by ADAR1 Partners, LP, (ii) 222,361 shares of Common Stock held by Spearhead Insurance Solutions IDF, LLC and (iii) 20,370 shares of Common Stock held by other separately managed accounts as of September 30, 2026. As the manager of ADAR1 Capital Management, LLC and ADAR1 Capital Management GP, LLC, Mr. Schneeberger may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP, Spearhead Insurance Solutions IDF, LLC and the separately managed accounts referenced above. Based on 110,870,300 shares of Common Stock of Freenome, Inc. (the "Issuer") outstanding as of September 30, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026, filed with the Securities and Exchange Commission on November 12, 2026.

Item 1

Issuer

Freenome, Inc.

Principal executive office address

Genesis Marina, 3300 Marina Blvd, Brisbane, CA 94005

Item 2

Citizenship

(i) ADAR1 Capital Management is a Texas limited liability company; (ii) ADAR1 General Partner is a Texas limited liability company; and (iii) Mr. Schneeberger is a citizen of Switzerland.

Filing person

This Schedule is being filed on behalf of each of the following persons (each, a "Reporting Person" and collectively, the "Reporting Persons"): (i) ADAR1 Capital Management, LLC ("ADAR1 Capital Management"); (ii) ADAR1 Capital Management GP, LLC ("ADAR1 General Partner"); and (iii) Daniel Schneeberger ("Mr. Schneeberger").

Principal business or residence address

The address of the principal business office of each of the Reporting Persons is 3503 Wild Cherry Drive, Building 9, Austin, Texas 78738.

Item 3

Not applicable indication

N

Type of filing person

IA · HC

Item 4

Percent of class

The information contained on the cover pages of this Schedule 13G is incorporated herein by reference.

Amount beneficially owned

The information contained on the cover pages of this Schedule 13G is incorporated herein by reference.

Sole voting power

The information contained on the cover pages of this Schedule 13G is incorporated herein by reference.

Shared voting power

The information contained on the cover pages of this Schedule 13G is incorporated herein by reference.

Sole dispositive power

The information contained on the cover pages of this Schedule 13G is incorporated herein by reference.

Shared dispositive power

The information contained on the cover pages of this Schedule 13G is incorporated herein by reference.

Item 5

Not applicable indication

N

Ownership of 5% or less

Y

Item 6

Not applicable indication

Y

Item 7

Not applicable indication

N

Subsidiaries

Mr. Schneeberger is filing this Schedule 13G as a control person in respect of shares beneficially owned by ADAR1 Capital Management, an investment adviser as described in SS 240.13d-1(b)(1)(ii)(E).

Item 8

Not applicable indication

Y

Item 9

Not applicable indication

Y

Item 10

Not applicable indication

N

Certifications

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

Signature 1

Reporting person
ADAR1 Capital Management, LLC
Signed
/s/ Daniel Schneeberger
Title
Daniel Schneeberger, Manager
Date
11/16/2026

Signature 2

Reporting person
ADAR1 Capital Management GP, LLC
Signed
/s/ Daniel Schneeberger
Title
Daniel Schneeberger, Manager
Date
11/16/2026

Signature 3

Reporting person
Daniel Schneeberger
Signed
/s/ Daniel Schneeberger
Title
Daniel Schneeberger, in his individual capacity
Date
11/16/2026

Company context

Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company’s proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. Freenome’s development of SimpleScreen™ CRC for colorectal cancer screening and a pipeline of tests for lung cancer and additional indications is designed to increase cancer detection among millions of at-risk individuals. For more information, visit www.freenome.com.

Current securities

Historical securities (1)

Recent company filings

  1. SCHEDULE 13G/A - filed by PERCEPTIVE ADVISORS LLC regarding Freenome, Inc.Nov 16, 2026
  2. SCHEDULE 13G/A - filed by Point72 Asset Management, L.P. regarding Freenome, Inc.Nov 16, 2026
  3. SCHEDULE 13G/A - filed by Holocene Advisors, LP regarding Freenome, Inc.Nov 16, 2026
  4. SCHEDULE 13G/A - filed by One Fin Capital Management LP regarding Freenome, Inc.Nov 16, 2026
  5. SCHEDULE 13G/A - filed by RTW INVESTMENTS, LP regarding Freenome, Inc.Nov 16, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.